Contact this trialFirst, we need to learn more about you.
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor
AMG 193 + Docetaxel for Advanced Solid Cancers
Recruiting1 awardPhase 1 & 2
New York, New York
This trial tests AMG 193 in adults with advanced cancers. The drug aims to specifically attack these cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service